Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Herbert J. Zeh"'
Autor:
Herbert J. Zeh, Brandon A. Mahal, Nina N. Sanford, Todd A. Aguilera, John C. Mansour, Chul Ahn, Muhammad Shaalan Beg, Michael R. Folkert, David J. Sher
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:1292-1300
Background: Adjuvant therapy for resected pancreatic adenocarcinoma was given a category 1 NCCN recommendation in 2000, yet many patients do not receive chemotherapy after definitive surgery. Whether sociodemographic disparities exist for receipt of
Autor:
Ahmad Hamad, Aatur D. Singhi, Herbert J. Zeh, Rula Amarin, Nathan Bahary, Kevin McGrath, Amer H. Zureikat
Publikováno v:
Journal of the National Comprehensive Cancer Network. 15:983-988
Overexpression of HER2 protein and amplification of the ERBB2 gene has been observed in various adenocarcinomas, providing a therapeutic target that can be used to extend the survival of a select cohort of patients. Anti-HER2 therapy has been success
Autor:
Anil K. Dasyam, Inderpal S. Sarkaria, Siraj M. Ali, Jeffrey S. Ross, Khanh Nguyen, Jon Chung, Marina N. Nikiforova, Jill Lacy, Nathan Bahary, Jamie Koo, Andrew Eugene Hendifar, Aatur D. Singhi, Herbert J. Zeh, Joel R. Greenbowe
Publikováno v:
Journal of the National Comprehensive Cancer Network. 15:555-562
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers, with a 5-year survival of 8%. Current therapeutic regimens are largely ineffective and underscore the need for novel treatment strategies. Chromosomal rearrangements involving